Six to buy
Morgan Stanley
(Investors Chronicle) There are plenty of reasons to dodge the banking sector: rock bottom interest rates and economic weakness will weigh on profitability over the coming years. An “ever-shifting” regulatory backdrop means investment banks are no haven, but Morgan Stanley is better placed than most. Its growing wealth-management and investment-management divisions provide valuable diversification, and the bank has little exposure to the rickety consumer credit and mortgage markets. On a price/earnings (p/e) ratio of 9.5 the shares have room to close a valuation gap with peers. $51.70
Saga
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(Interactive Investor) Shares in this over-50s insurer and cruise operator have jumped on hopes for the vaccines in development. The insurance side has broken even this year thanks to lower vehicle claims as lockdowns keep more people off the roads. The outlook now “hinges” on the cruising division. The industry has plenty of devoted fans and Saga’s premium cruise offering occupies an “attractive marketing” niche. If you think new vaccines will help release “pent-up demand” from prosperous pensioners next year, then buy. 183p
Schroders British Opportunities Trust
(The Mail on Sunday) The rout in the London market has left many of the best small and medium-sized British businesses strapped for investment cash, hampering their growth prospects. This soon-to-float trust aims to remedy that problem. The plan is to invest in about 30 to 50 companies split evenly between publicly listed and private businesses. Schroders has a good track record and the trust’s liquid structure will save investors from a Woodford-style meltdown if things go wrong. The deadline to apply for the share issue is November 26. “A patriotic buy.” 100p
Starbucks Corporation
(Shares) This “coffeehouse colossus” has 32,000 stores across 80 countries. American and Chinese sales have rebounded strongly since the first wave of lockdowns, with lower footfalls partially offset by higher-priced drinks and an “industry-leading” digital-ordering platform. The group is likely to emerge from the pandemic even more dominant as lockdowns decimate the competition. The shares are not cheap on 31.9 times 2021 earnings, but this is “a business full of beans”. $95
WHSmith
(The Sunday Telegraph) WHSmith’s shift from the floundering high street to outlets in transport hubs looked “inspired” until the pandemic struck. Its resilience in the face of the challenge has been “exemplary”: cost cutting means it needs only half of its normal footfall to break even. That is a testament to a strong corporate culture, helped by a succession of CEOs who have been recruited internally and know the business inside out. The firm is poised to profit from the rebound and the shares offer value. 1,353p
Wizz Air
(The Wall Street Journal) This London-listed Hungarian airline offers the best of both worlds: a pandemic recovery bet combined with a growth play. Around 65% of Wizz’s passengers are travelling to visit family and friends elsewhere in Europe, making the business “unusually resistant” to the frail tourism market. Indeed, Wizz briefly became the continent’s biggest airline during the spring lockdown. On a longer view, structural growth in its “core eastern European market” will provide a tailwind. The travails of Norwegian also create an opportunity to break into the long-haul market. 4,280p
...and the rest
The Daily Telegraph
Housebuilder Vistry trades on a 24% discount to net asset value (NAV) but the government will prop up the housing market “come what may”. Buy (711p). The Baillie Gifford China Growth Trust has an excellent track record but given an “eye-watering” 19% premium to NAV it is time to take profits. Sell (532p).
Investors Chronicle
“Digitally-focused” academic publisher-to-business analytics business Relx boasts a vast “archive of content and data” that helps fend off competition. A 2.6% dividend yield is also appealing. Buy (1,837p).
The Mail on Sunday
Post-pandemic construction and garden upgrades are auspicious for outdoor paving specialist Marshalls. A “robust, long-term investment” (795p).
Shares
The pandemic is accelerating the “mega-trend” towards online retailing. Leading digital payments service PayPal is ideally placed to profit – buy ($184.72). The Aberdeen Standard Asia Focus investment trust offers exposure to important Asian growth themes such as rising healthcare demand and e-commerce (1,031p). Shares in Mr Kipling cakes-owner Premier Foods have doubled since April but on a forward p/e of 9.4 they still look a tasty morsel. Hold (98p).
The Times
Shares in private-equity investor 3i Group have done well recently but on a forward p/e of just 6.3 this diverse portfolio still has room to deliver. Buy (1,111p). Building supplier Grafton Group is cashing in on the lockdown DIY boom but is still on a discount to historic levels. Buy (816p).
-
Lloyds axes foreign currency fees for Club Lloyds customersClub Lloyds customers will be able to withdraw their money abroad without incurring any extra fees
-
How to invest during stagflationTrump’s tariffs look poised to push the global economy into a period of stagflation. We look at how to ensure your investments can survive a global slowdown.
-
The star small and mid-cap stocks income investors have overlookedOpinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
-
Falling revenues and mounting debt spell trouble for Jumia TechnologiesStruggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
-
Chemring Group: an explosive investment opportunity in defenceEuropean states are raising their military spending, and Chemring Group looks well placed to profit
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
-
Best of British bargains: cash in on undervalued companies in the UK stock marketOpinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
-
Building firm Keller presents low debt and ample scope for growthGeotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
-
PZ Cussons share price down 75% in last decade – why it's one to watchOpinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharmaOpinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
